A Phase 1 Study of SB1518 for the Treatment of Advanced Lymphoid Malignancies

NCT00741871 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

35

Enrollment

INDUSTRY

Sponsor class

Conditions

Lymphoma, Malignant
Hodgkin's Lymphoma
B Cell Lymphoma

Interventions

DRUG: SB1518

Sponsor

S*BIO